Star Combo Pharma Ltd (S66) — Cash Flow-to-Debt Ratio
Star Combo Pharma Ltd (S66) has a Cash Flow-to-Debt Ratio of 0.07x as of December 2025, meaning its operating cash flow of AU$575.23K could theoretically repay 0% of its total liabilities (AU$8.30 Million) in one year. Check total reinvestment intensity of Star Combo Pharma Ltd to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Star Combo Pharma Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Star Combo Pharma Ltd across 10 annual periods. Also explore balance sheet size of Star Combo Pharma Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Star Combo Pharma Ltd (2016–2025)
Year-by-year debt coverage analysis for Star Combo Pharma Ltd. For market capitalisation and broader financial context, see market value of Star Combo Pharma Ltd.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.17x | AU$11.94 Million | AU$10.19 Million | ▲ +3546.3% |
| 2024 | -0.03x | AU$-316.45K | AU$9.30 Million | ▼ -116.3% |
| 2023 | 0.21x | AU$1.88 Million | AU$8.97 Million | ▲ +1831.2% |
| 2022 | 0.01x | AU$87.11K | AU$8.04 Million | ▼ -76.7% |
| 2021 | 0.05x | AU$331.53K | AU$7.13 Million | ▲ +146.7% |
| 2020 | -0.10x | AU$-1.02 Million | AU$10.22 Million | ▲ +65.8% |
| 2019 | -0.29x | AU$-2.19 Million | AU$7.51 Million | ▲ +56.0% |
| 2018 | -0.66x | AU$-1.84 Million | AU$2.78 Million | ▼ -358.1% |
| 2017 | 0.26x | AU$932.20K | AU$3.64 Million | ▼ -36.6% |
| 2016 | 0.40x | AU$1.30 Million | AU$3.21 Million | — |